# A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty

> **NCT01285024** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 109 (actual)

## Conditions studied

- Arthritis

## Interventions

- **DEVICE:** Vitagel

## Key facts

- **NCT ID:** NCT01285024
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2017-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285024, "A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01285024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*